Answers are grounded in this paper and cite their sources.
Clinical neurology is an exciting area of therapeutics. There have been profound drug advances in each of its diverse areas; however, there are still concerns about the best treatment strategies and their relative safety, outcomes, quality-of-life impact and costs. For this inaugural issue of Therapeutic Advances in Neurological Disorders, we asked our international editorial board to give us their opinion on significant therapeutic advances in their area of neurology, what the future holds, and what needs to be addressed. This snapshot provides a clinical picture of where we are and where we should head in the years to come. Of course, there is some overlap in opinion, but there is also diversity - the point being that collectively, there will be progress in the drug treatment of neurological disorders. Not all of the areas we cover in the journal are presented, and they may form the basis of a future editorial.
No takes yet. Share an insight, caveat, or question.
Gordon Mallarkey (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: